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The differences between Escherichia coli strains associated with symptomatic and asymptomatic urinary tract infections (UTIs) 
remain to be properly determined. Here we examined the prevalence of plasmid types and bacteriocins, as well as genetic related­
ness, in a defined collection of E. coli strains that cause UTIs. Comparative analysis identified a subgroup of strains with a high 
number of virulence genes (VGs) and microcins M/H47. We also identified associations between microcin genes, VGs, and spe­
cific plasmid types.
Urinary tract infections (UTIs) are among the most common infectious diseases of humans (17). Uropathogenic Esche­
richia coli (UPEC) is the major etiological agent of UTIs and can 
cause both symptomatic infection and asymptomatic bacteriuria 
(ABU) in catheterized (CA-ABU) and noncatheterized patients 
with ABU. Two recent studies identified and compared the viru­
lence gene (VG) carriage of E. coli strains isolated from patients 
with ABU, CA-ABU, and symptomatic UTIs (13, 21). However, 
the prevalence of plasmid types and bacteriocins and the genetic 
relatedness of these strains were not elucidated. Here we have 
examined these features in the same set of E. coli strains that cause 
UTIs by determining the prevalence of different plasmid incom­
patibility types and sequence types (STs), the distribution of coli- 
cin and microcin genes, and their random amplified polymorphic 
DNA (RAPD) profile.
A collection of 159 UTI-causing E. coli strains consisting of 51 
ABU, 62 CA-ABU, and 44 symptomatic UTI-causing strains 
(comprising 25 pyelonephritis and 19 cystitis strains) were used in 
this study (13, 21). The ABU prototype strain 83972 (2, 11) and 
the ABU E. coli reference strain (ECOR) 71 were also used in this 
study. All strains have been previously characterized for the 
prevalence of 18 VGs and Clerm ont phylogenetic groups (13, 
21). These data were used for the com parative analysis with 
plasm id types and bacteriocins and RAPD analysis in this 
study. DNA extraction from  the isolates was perform ed as p re­
viously described (1).
Plasmid replicon typing was carried out to investigate the pres­
ence of 18 replicons using three multiplex panels (5, 8). The pres­
ence of the following 16 bacteriocins was assessed by multiplex 
PCRs: colicins A, B, D, E l, E2, E3, E6, E7, Ia/Ib, K, M, and V and 
microcins B17, H47, J25, and M. The PCR primers and pools are 
described in Table SI in the supplemental material. The genetic 
relatedness of the UTI-causing strains was assessed by RAPD anal­
ysis using primer 1254 (CCGCAGCCAA) (14). The prevalence of 
the three most common STs (ST69, ST95, and ST131) associated 
with E. coli UTIs were also investigated using previously described 
methods (3, 7). Comparisons of prevalence among the different 
groups of E. coli were analyzed using the x 2 test (n >  5) and 
Fisher’s exact test (n <  5) using SPSS (version 17) software. The 
likelihood ratio y2 and Kappa (k) index was used to quantify the 
degree of coassociation between genes.
Plasmid typing revealed 14 different plasmid replicons, with 
84% of the strains carrying at least one plasmid replicon (Table 1 
and Fig. 1). The most common plasmid replicons identified were 
Inc FIB (present in 103/159 strains [65%]) andFrep FII, Fill, FIV, 
and FV variants of IncF (present in 108/159 strains [68%]). The 
B/O plasmid replicon was more prevalent in symptomatic UTI 
strains (23%) than in ABU strains (8%; P = 0.0342), while the FIB 
replicon was more prevalent in CA-ABU strains (74%) than in 
ABU strains (51%) (P = 0.0098). None of the strains contained 
the Inc A/C, T, K/B, and H12 plasmid replicons.
No significant difference was observed in the prevalence of 
bacteriocin genes between ABU, CA-ABU, and symptomatic UTI 
strains. Bacteriocin genes were detected in 56% of strains; 29% of 
strains contained colicin genes, and 38% contained microcin 
genes. Microcin M (31%) and H47 (30%) and colicin Ia/Ib (14%), 
El (12%), and V (11%) were the most common bacteriocin genes. 
Colicins A, D, E2, and E6 were not detected in any of the strains.
The cooccurrence of bacteriocin genes was also examined (see 
Table S2 in the supplemental material). A significant coassocia­
tion of microcin M and H47 genes was identified (likelihood ratio 
X 2 = 122.254 and P <  0.0001). Out of the 49 strains that harbored 
the microcin M gene, 43 strains (88%) also carried microcin H47 
gene. A similar coassociation was observed between colicin V and 
Ia/Ib (likelihood ratio y2 = 84.545 and P <  0.0001). Microcin 
genes were more prevalent in strains belonging to phylogenetic 
group B2 (53% [P = 0.003]) compared to strains in groups A and 
B1 (33%) and D (22%).
RAPD analysis resolved 3 major clusters with 60% band simi­
larity and 7 independent branches with 70% band similarity (see 
Fig. SI in the supplemental material). There was a strong correla­
tion between RAPD profiling and phylogenetic group typing. The 
likelihood of each phylogenetic group clustering together on the
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T A B LE 1 Distribution o f bacteriocins, plasmid replicons, and phylogenetic groups am ong E. coli strains causing ABU, CA-ABU, and 
symptomatic UTIs
N o. o f  strains (% ) causing: Statistical significance o f  prevalence0
Gene o r rep licon ABU (n =  53) CA-ABU (n =  62) Sym ptom atic  U TI (n =  44)
ABU vs
ABU vs CA-ABU sym ptom atic  U TI
CA-ABU vs 
sym ptom atic  UTI
Plasm id replicons
B/O 4 (8 ) 10 (16) 10 (23) NS 0.0342 NS
FIC 1 (2) 0 (0 ) 0 (0 ) NS NS NS
P 0 (0 ) 1 (2) 0 (0 ) NS NS NS
W 2 (4 ) 0 (0 ) 0 (0 ) NS NS NS
FIIA 1 (2) 2 (3 ) 0 (0 ) NS NS NS
FIA 6 (1 1 ) 7 (1 1 ) 4 (9 ) NS NS NS
FIB 27 (51) 46 (74) 30 (68) 0.0098 NS NS
Y 5 (9 ) 0 (0 ) 1 (2) 0.0187 NS NS
11 3 (6 ) 5 (8 ) 4 (9 ) NS NS NS
Frep 30 (57) 49 (79) 29 (66) 0.0097 NS NS
X 0 (0 ) 2 (3 ) 0 (0 ) NS NS NS
HI1 0 (0 ) 3 (5 ) 2 (5 ) NS NS NS
N 2 (4 ) 2 (3 ) 1 (2) NS NS NS
L/M 0 (0 ) 0 (0 ) 1 (2) NS NS NS
Bacteriocins
Colicins
B 2 (4 ) 1 (2) 0 (0 ) NS NS NS
E l 6 (1 1 ) 10 (16) 3 (7 ) NS NS NS
E3 1 (2) 0 (0 ) 0 (0 ) NS NS NS
E7 2 (4 ) 0 (0 ) 0 (0 ) NS NS NS
K 1 (2) 2 (3 ) 4 (9 ) NS NS NS
Ia/Ib 6 (1 1 ) 9 (1 5 ) 7 (1 6 ) NS NS NS
M 1 (2) 1 (2) 0 (0 ) NS NS NS
M icrocins
V 6 (1 1 ) 5 (8 ) 6 (1 4 ) NS NS NS
B17 2 (4 ) 4 (6 ) 1 (2) NS NS NS
H 47 12 (23) 23 (37) 12 (27) NS NS NS
M 15 (28) 22 (35) 12 (27) NS NS NS
J25 0 (0 ) 2 (3 ) 0 (0 ) NS NS NS
Sequence types
ST95 4 (8 ) 6 (1 0 ) 12 (27) NS 0.0090 0.0174
ST131 2 (4 ) 4 (7 ) 4 (9 ) NS NS NS
ST69 0 (0 ) 0 (0 ) 0 (0 ) NS NS NS
Phylogenetic g roups
A 5 (9 ) 6 (1 0 ) 1 (2) NS NS NS
B l 3 (6 ) 2 (3 ) 1 (2) NS NS NS
B2 37 (70) 44 (71) 34 (77) NS NS NS
D 8 (1 5 ) 10 (16) 8 (1 8 ) NS NS NS
aNS, n o t  sta tistically  significant.
basis of RAPD profiles was as follows: B2, x 2 =  49.5 and P < 
0.0001; D, x2 =  41.1 and P <  0.0001; A, *2 =  9.0 and P = 0.041; 
Bl, x 2 =  9.15 and P = 0.076.
The analysis of the three common STs revealed that ST95 
(14%) was more common than ST131 (6%) and ST69 (not de­
tected). All of the ST95 and ST131 isolates were identified as B2 
strains. The ST95 strains were significantly associated with strains 
causing symptomatic UTIs (27%) compared to strains causing 
ABU (8%; P = 0.009) and CA-ABU (10%; P = 0.0174). A signif­
icant coassociation of colicin V and Ia/Ib genes was also observed 
in the ST95 strains (likelihood ratio x 2 =  28.4 and P <  0.0001) 
(see Table S2 in the supplemental material). None of the ST131 
strains contained any bacteriocin genes tested for in this study
(Fig. 1).
Cluster analysis using VGs, bacteriocin genes, and plasmid rep- 
licon types separated a group of strains (cluster 1) harboring a 
large num ber ofVGs (median score of 9 VGs). Cluster 1 contained 
55 strains with a substantial mix from all the three UTI groups 
(27% of ABU, 42% CA-ABU, and 31% of symptomatic UTI 
strains).The strains in this cluster belonged predominantly to 
phylogenetic group B2 (95%). All of the strains in cluster 1 con­
tained the iroN gene, while the majority of strains contained the 
toxin genes hlyA (93%) and cnfl (91%) and F1C fimbrial gene 
focG (97%). Forty-seven strains in cluster 1 contained the micro- 
cin M gene; 87% of these strains also contained the microcin H47 
gene. A significant coassociation of the microcin M/H47 genes 
with hlyA, cnfl,focG, and iroN was also observed (see Table S2 in 
the supplemental material). Overall, the major difference between
1028 jcm.asm.org Journal of Clinical Microbiology
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FIG 1 C luster analysis based  o n  VGs, bacteriocins, p lasm id  types, an d  sequence types c reated  using  Jaccard co rre la tio n  a nd  com ple te  linkage. T he  d end ro g ram  
shows the  RAPD profiles o f  each isolate. G reen, p urp le , an d  red  rep resen t s tra ins causing  sym ptom atic  U TI, ABU, a n d  CA-ABU, respectively. B acterial stra ins and  
the ir respective phylogenetic g roups  a re  also indicaated .
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strains in cluster 1 and clusters 2 to 5 was the presence of the 
microcin M/H47 genes.
Bacteriocin gene analysis revealed that microcin genes were 
more prevalent than colicin genes. A coassociation of microcin 
M/H47 and colicin V and Ia/Ib was observed. The isolates that 
carried microcin M/H47 predominantly belonged to phylogenetic 
group B2. The isolates that possessed microcin M /H47 genes were 
also associated with the carriage of a greater num ber of VGs (me­
dian VG score of 9) compared to the isolates that did not carry 
M/H47 genes (median score of 5 VGs). Cluster analysis using all 
three markers (VG, bacteriocins, and plasmid replicons) (Fig. 1) 
demonstrated that microcin M/H47 carrying isolates shared a VG 
profile that was distinct from all other strains. This was further 
supported by the RAPD analysis, which revealed that there was 
minimal genetic diversity within this cluster in comparison to 
strains that lacked the M/H47 microcin genes (Fig. 1). One isolate 
in this cluster belonged to the ST131 lineage, and three isolates 
belonged to the ST95 lineage (7, 15, 18, 20). Taken together, the 
data suggest that the group of strains that formed cluster 1 are 
genetically distinct from other strains examined in this study.
A highly significant coassociation between the M/H47 micro­
cin genes and hlyA, cnfl,focG, and iroN was observed among the 
strains in cluster 1. Previous reports have shown that these genes 
are often located on the same pathogenicity island (PAI) (12, 16, 
19), and this would also explain our data. In addition, PAI- 
CFT073-serX contains the microcin M/H47 gene cluster, F lC fim - 
brial genes, and the iro gene cluster (4). The genetic arrangement 
of these genes in the strains examined in this study remains to be 
determined.
The comprehensive genotyping employed in this study could 
not clearly differentiate the E. coli strains based on clinical UTI 
types. Many of the ABU strains were similar to CA-ABU and 
symptomatic UTI strains based on RAPD patterns, VG profiling, 
bacteriocins, and plasmid types. Interestingly, we identified ABU 
and CA-ABU strains that possessed similar properties to the pro­
totype ABU E. coli strain 83972 (2, 9,11). This suggests that atten­
uation of ABU and CA-ABU strains through gene loss and/or 
mutation m aybe a common occurrence (9,10, 22).
Plasmid typing revealed differences in the prevalence of plas­
mids among the E. coli strains based on UTI severity. There was a 
high prevalence of FIB plasmids in the CA-ABU and symptomatic 
UTI strains; these conjugative plasmids have also been shown to 
contribute to biohlm formation (6). Further investigation into the 
dissemination of specific plasmid types and their involvement in 
virulence and antibiotic resistance is necessary to understand the 
epidemiology of UTI-causing E. coli.
In summary, this study identified a cluster of similar UTI- 
causing E. coli strains associated with symptomatic and asymp­
tomatic UTIs. The association between microcin and VGs, as well 
as the high prevalence of specific plasmid types, might reflect char­
acteristics associated with an enhanced ability to colonize the uri­
nary tract.
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